CLINICAL_TRIALS
trial_result
· 2021-01-05
Clinical Trial Update: Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma [NA]
Summary
A completed trial evaluating intravitreal aflibercept for neovascular glaucoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Neovascular Glaucoma | NA | Status: COMPLETED | Results posted: 2021-01-05